| Test |
In Range |
Out Of Range |
Units |
Reference |
| Comp Metabolic Pnl |
| Sodium |
142 |
|
mmol/L |
136 - 145 |
| Potassium |
4.5 |
|
mmol/L |
3.5 - 5.1 |
| Chloride |
103 |
|
mmol/L |
98 - 107 |
| CO2 |
32 |
|
mmol/L |
21 - 32 |
| Anion Gap |
6.9 |
|
mmol/L |
3 - 12 |
| Glucose |
91 |
|
mg/dL |
70 - 99 |
| BUN |
|
19 H |
mg/dL |
7 - 18.0 |
| Creatinine |
|
1.5 H |
mg/dL |
0.8 - 1.3 |
| eGFR-Other |
|
L 49 |
See Comment |
> 60 |
| eGFR-African American |
|
L 60 |
See Comment |
> 60 |
| |
| Units: ml/min/1.73 m2. Estimated Glomerular Filtration Rate values are calculated by MDRD equation and are valid only if creatinine level is stable. GFRs are most accurate for results 60 ml/min/1.73 m2 or less. Reference: www.nkdep.nih.gov/professionals/index.htm |
| |
| Calcium |
9.1 |
|
mg/dL |
8.5 - 10.1 |
| Total Protein |
7.2 |
|
g/dL |
6.2 - 8.5 |
| Albumin |
4.2 |
|
g/dL |
3.4 - 5.0 |
| Bilirubin, Total |
0.6 |
|
mg/dL |
< 1.1 |
| Alkaline Phosphatase |
85 |
|
U/L |
50 - 136 |
| AST |
18 |
|
U/L |
15 - 37 |
| ALT |
37 |
|
U/L |
30 - 65 |
| |
| Lipid Profile |
| Cholesterol |
196 |
|
mg/dL |
< 200 |
| Triglyceride |
71 |
|
mg/dL |
< 150 |
| HDL |
92 |
|
mg/dL |
> 40 |
| LDL (calculated) |
90 |
|
mg/dL |
< 100 |
| Cholesterol:HDL Ratio |
2.1 |
|
|
< 5.0 |
| |
| |
Cholesterol / HDL Cholesterol Ratio Interpretation |
| |
Risk |
Female |
Male |
|
| |
1/2 Average |
3.27 |
3.34 |
|
| |
Average |
4.44 |
4.97 |
|
| |
2X Average |
7.05 |
9.55 |
|
| |
3X Average |
11.04 |
23.39 |
|
| |
| VLDL (calculated) |
14 |
|
mg/dL |
5 - 40 |
| |
| Prolactin |
4.9 |
|
ng/mL |
2.1 - 17.7 |
| |
| Free T3 |
2.73 |
|
pg/mL |
2.3 - 4.2 |
| T3, Total |
115 |
|
ng/dL |
87 - 167 |
| THS 3rd Generation |
1.530 |
|
mIU/L |
0.400 - 4.500 |
| Free T4 |
1.03 |
|
ng/dL |
0.80 - 1.80 |
| Thyroglobulin AutoAb |
< 20 |
|
IU/mL |
< 20 |
| TSI (Thyroid Stimulating Immunoglogulin) |
< 89 |
|
% |
< 140% baseline |
| |
| Thyroid stimulating immunoglobulins (TSI) can engage the TSH receptors resulting in hyperthyroidism in Graves' disease patients. TSI levels can be useful in monitoring the clinical outcome of Graves' disease as well as assessing the potential for hyperthyroidism from maternal-fetal transfer. TSI results greater than or equal to (>=) 140% of the Reference Control are considered positive. |
| |
| NOTE: A serum TSH level greater than 350 micro-International Units/mL can interfere with the TSI bioassay and potentially give false positive results. |
| |
| The performance characteristics of this assay have been determined by Quest Diagnostics Nichols Institute, San Juan Capistrano. Performance characteristics refer to the analytical performance of the test. |
| |
| RPR |
Non Reactive |
|
|
NRX |
| |
| Testosterone, Total |
743 |
|
ng/dL |
241 - 827 |
| |
| CBC w Auto Diff |
| Test |
In Range |
Out Of Range |
Units |
Reference |
| WBC Count |
4.2 |
|
K/uL |
4.0 - 11.0 |
| RBC Count |
4.56 |
|
M/uL |
4.40 - 6.00 |
| Hemoglobin |
14.1 |
|
g/dL |
13.5 - 18.0 |
| Hematocrit |
42.3 |
|
% |
40.0 - 52.0 |
| MCV |
93 |
|
fL |
80 - 100 |
| MCH |
30.9 |
|
pg |
27.0 - 33.0 |
| MCHC |
33.3 |
|
g/dL |
31.0 - 36.0 |
| RDW |
13.6 |
|
% |
< 16.4 |
| Platelet Count |
232 |
|
K/uL |
150 - 400 |
| Diff Type |
Automated |
|
|
|
| Neutrophil |
54 |
|
% |
49.0 - 74.0 |
| Lymphocytes |
33 |
|
% |
26.0 - 46.0 |
| Monocyte |
9 |
|
% |
2.0 - 12.0 |
| Eosinophil |
3 |
|
% |
0.0 - 5.0 |
| Basophil |
1 |
|
% |
0.0 - 2.0 |
| Abs. Neutrophil |
2.3 |
|
K/uL |
2.0 - 8.0 |
| Abs. Lymphocyte |
1.4 |
|
K/uL |
1.0 - 5.1 |
| Abs. Monocyte |
0.4 |
|
K/uL |
0.0 - 0.8 |
| Abs. Eosinophil |
0.1 |
|
K/uL |
0.0 - 0.5 |
| Abs. Basophil |
0.0 |
|
K/uL |
0.0 - 0.2 |